Research across Heart Defects, Congenital
Related studies from across the Heart Defects, Congenital family.
11 trials tracked for Atrial septal defect: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 6 citations.
Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
In the management of atrial septal defect, the administration of Ropivacaine 0.2% Injectable Solution was associated with a significant reduction in the total amount of opioid medications administered (p=0.004) 3.
The use of Dexmedetomidine in combination with Sevoflurane resulted in measurable changes in hemodynamic variables during administration (p=0.05) 4.
AI synthesis of 4 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
Related studies from across the Heart Defects, Congenital family.